Resident memory CD8+ TC cells specific for SARS-CoV-2 persist in the nasal mucosa for at least two months after recovery from COVID-19 [68], and it seems likely that, analogous to influenza, they help resolve the infection in the URT and provide protective immunity in subsequent exposure to the virus. This evidence concerns the gene CD8A and COVID-19.